From Threat to Cure: Understanding of Virus-Induced Cell Death Leads to Highly Immunogenic Oncolytic Influenza Viruses

The authors discuss strategies for targeting viral replication to cancerous lesions and arming them with immunogenic transgenes. They describe which modes of cell death are induced by influenza A virus infection and how these insights may be utilized to optimize influenza A virus-based oncolytic virus design.
[Cell Death Discovery]
Full Article
Bookmark

No account yet? Register

0
Share

Adamis Pharmaceuticals Announces License to Commercialize Tempol, a Novel Investigational Anti-inflammatory and Antioxidant Drug for the Treatment of Respiratory Diseases Including COVID-19

Adamis Pharmaceuticals Corporation announced a license to commercialize Tempol, a novel patented investigational drug for the treatment of COVID-19. The license includes the worldwide use of Tempol for the treatment of all respiratory diseases including asthma, respiratory syncytial virus, influenza and COVID-19.
[Adamis Pharmaceuticals]
Press Release
Bookmark

No account yet? Register

0
Share

Systemically Comparing Host Immunity between Survived and Deceased COVID-19 Patients

Scientists summarized the characteristics of cellular immune responses in a total of 157 COVID-19 patients enrolled in Tongji Hospital between February and March 2020 and compare the properties between 95 survived and 62 deceased patients with different onset time.
[Cellular & Molecular Immunology]
Full Article
Bookmark

No account yet? Register

0
Share

Pluristem Announces Activation of Clinical Sites and Commencement of Patient Enrollment in US FDA Phase II COVID-19 ARDS Trial

Pluristem Therapeutics, Inc. announced the activation of clinical sites and initiation of enrollment in its Phase II US FDA study of PLX cells for the treatment of severe COVID-19 complicated by Acute Respiratory Distress Syndrome (ARDS).
[Pluristem Therapeutics, Inc. ]
Graphical Abstract
Bookmark

No account yet? Register

0
Share

Optimization of Primer Sets and Detection Protocols for SARS-CoV-2 of Coronavirus Disease 2019 (COVID-19) Using PCR and Real-Time PCR

Scientists provide three-step guidelines for the design and optimization of specific primer sets. The three steps include the selection of primer sets for target genes in the genome of SARS-CoV-2, the in silico validation of primer and amplicon sequences, and the optimization of PCR conditions for specific hybridization between the primers and target genes, and the elimination of spurious primer dimers.
[Experimental and Molecular Medicine]
Optimization of primer sets and detection protocols for SARS-CoV-2 of coronavirus disease 2019 (COVID-19) using PCR and real-time PCR | Experimental & Molecular Medicine. (n.d.). Retrieved June 17, 2020, from https://www.nature.com/articles/s12276-020-0452-7 Cite
Full Article
Bookmark

No account yet? Register

0
Share

UCLA Receives Nearly $14 Million from NIH to Investigate Gene Therapy to Combat HIV

University of California, Lost Angeles (UCLA) researchers and colleagues have received a $13.65 million grant from the National Institutes of Health to investigate and further develop an immunotherapy known as CAR T, which uses genetically modified stem cells to target and destroy HIV.
[Univesity of California, Los Angeles]
Graphical Abstract
Bookmark

No account yet? Register

0
Share

Potential Antiviral Options against SARS-CoV-2 Infection

Investigators developed a neutralization assay using SARS-CoV-2 strain and Vero-E6 cells. They identified the most potent sera from recovered patients for the treatment of SARS-CoV-2-infected patients. They also screened 136 safe-in-man broad-spectrum antivirals against the SARS-CoV-2 infection in Vero-E6 cells and identified nelfinavir, salinomycin, amodiaquine, obatoclax, emetine and homoharringtonine.
[Viruses]
Full Article
Bookmark

No account yet? Register

0
Share

HIV-1-Associated Left Ventricular Cardiac Dysfunction in Humanized Mice

Longitudinal echocardiography was used to assess whether NOD.Cg-PrkdcscidIl2rgtm1Wjl/SzJ mice reconstituted with human hematopoietic stem cells and infected with HIV-1ADA could recapitulate the salient features of HIV-1 infection.
[Scientific Reports]
Abstract
Bookmark

No account yet? Register

0
Share

CBASS Immunity Uses CARF-Related Effectors to Sense 3′–5′- and 2′–5′-Linked Cyclic Oligonucleotide Signals and Protect Bacteria from Phage Infection

Investigators discovered Enterobacter cloacae CD-NTase-associated protein 4 (Cap4) as a founding member of a diverse family of >2,000 bacterial receptors that responded to CD-NTase signals. Structures of Cap4 revealed a promiscuous DNA endonuclease domain activated through ligand-induced oligomerization.
[Cell]
AbstractGraphical Abstract
Bookmark

No account yet? Register

0
Share

Considering How Biological Sex Impacts Immune Responses and COVID-19 Outcomes

The authors discuss available sex-disaggregated epidemiological data from the COVID-19 pandemic, introduce sex-differential features of immunity and highlight potential sex differences underlying COVID-19 severity.
[Nature Reviews Immunology]
Full Article
Bookmark

No account yet? Register

0
Share

The Intermucosal Connection between the Mouth and Gut in Commensal Pathobiont-Driven Colitis

Investigators report that periodontal inflammation exacerbates gut inflammation in vivo. Periodontitis led to expansion of oral pathobionts, including Klebsiella and Enterobacter species, in the oral cavity.
[Cell]
The Intermucosal Connection between the Mouth and Gut in Commensal Pathobiont-Driven Colitis: Cell. (n.d.). Retrieved June 17, 2020, from https://www.cell.com/cell/fulltext/S0092-8674(20)30681-4 Cite
AbstractGraphical Abstract
Bookmark

No account yet? Register

0
Share
Share